Literature DB >> 8505328

N-recognin/Ubc2 interactions in the N-end rule pathway.

K Madura1, R J Dohmen, A Varshavsky.   

Abstract

The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. In the yeast Saccharomyces cerevisiae, substrates of the N-end rule pathway are targeted for degradation by a complex that includes the 225-kDa N-recognin, encoded by UBR1, and the 20-kDa ubiquitin-conjugating enzyme encoded by UBC2. We report that both physical stability and functional activity of the N-recognin.Ubc2 complex require the presence of a highly acidic 23-residue region at the C terminus of Ubc2. Ubc2-C88A, an inactive variant of Ubc2 in which the active-site Cys-88 has been replaced by Ala, is shown to retain the affinity for N-recognin. Expression of Ubc2-C88A inhibits the N-end rule pathway, apparently as a result of competition between Ubc2 and Ubc2-C88A for binding to N-recognin. The two-hybrid (interaction cloning) technique was used to identify a approximately 170-residue C-terminal fragment of the 1,950-residue N-recognin as a Ubc2-interacting domain. We also show that the level of UBR1 mRNA decreases upon overexpression of UBC2. This effect of UBC2 is observed with cells whose UBR1 is expressed from an unrelated promoter but is not observed if UBR1 contains a frameshift mutation, or if the Ubc2 protein lacks its C-terminal acidic region. The N-recognin.Ubc2 complex appears to regulate the expression of N-recognin through changes in the metabolic stability of its mRNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair.

Authors:  H D Ulrich; S Jentsch
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 2.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

3.  Interaction of the tail with the catalytic region of a class II E2 conjugating enzyme.

Authors:  Nadine Merkley; Gary S Shaw
Journal:  J Biomol NMR       Date:  2003-06       Impact factor: 2.835

4.  A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8.

Authors:  Danny T Huang; David W Miller; Rose Mathew; Robert Cassell; James M Holton; Martine F Roussel; Brenda A Schulman
Journal:  Nat Struct Mol Biol       Date:  2004-09-07       Impact factor: 15.369

5.  The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site.

Authors:  Bo Chen; Jennifer Mariano; Yien Che Tsai; Anna H Chan; Mickael Cohen; Allan M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

6.  A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation.

Authors:  Zlatka Kostova; Jennifer Mariano; Simone Scholz; Carolin Koenig; Allan M Weissman
Journal:  J Cell Sci       Date:  2009-04-14       Impact factor: 5.285

7.  Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins.

Authors:  Peter C W Lee; Mathew E Sowa; Steven P Gygi; J Wade Harper
Journal:  Mol Cell       Date:  2011-08-05       Impact factor: 17.970

8.  Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78.

Authors:  Ranabir Das; Jennifer Mariano; Yien Che Tsai; Ravi C Kalathur; Zlatka Kostova; Jess Li; Sergey G Tarasov; Robert L McFeeters; Amanda S Altieri; Xinhua Ji; R Andrew Byrd; Allan M Weissman
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

Review 9.  The N-end rule: functions, mysteries, uses.

Authors:  A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

10.  Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600.

Authors:  Kyung-Won Huh; Joseph DeMasi; Hidesato Ogawa; Yoshihiro Nakatani; Peter M Howley; Karl Münger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.